EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

An Overview of Drug Delivery Nanosystems for Sepsis-Related Liver Injury Treatment

Yi Lu, Yi Shi, Qian Wu, Xin Sun, Wei-Zhen Zhang, Xiao-Ling Xu, Wei Chen

International Journal of Nanomedicine · 2023-02 · Volume 18 · 765-779

DOI: 10.2147/ijn.s394802 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2023-02. Verfasst von Yi Lu und 6 weiteren Autor:innen. Beteiligte Einrichtung: ICU, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Sepsis, Blood Coagulation Disorders. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 120 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sepsis, which is a systemic inflammatory response syndrome caused by infection, has high morbidity and mortality. Sepsis-related liver injury is one of the manifestations of sepsis-induced multiple organ syndrome. To date, an increasing number of studies have shown that the hepatic inflammatory response, oxidative stress, microcirculation coagulation dysfunction, and bacterial translocation play extremely vital roles in the occurrence and development of sepsis-related liver injury. In the clinic, sepsis-related liver injury is mainly treated by routine empirical methods on the basis of the primary disease. However, these therapies have some shortcomings, such as serious side effects, short duration of drug effects and lack of specificity. The emergence of drug delivery nanosystems can significantly improve drug bioavailability and reduce toxic side effects. In this paper, we reviewed drug delivery nanosystems designed for the treatment of sepsis-related liver injury according to their mechanisms (hepatic inflammation response, oxidative stress, coagulation dysfunction in the microcirculation, and bacterial translocation). Although much promising progress has been achieved, translation into clinical practice is still difficult. To this end, we also discussed the key issues currently facing this field, including immune system rejection and single treatment modalities. Finally, with the rigorous optimization of nanotechnology and the deepening of research, drug delivery nanosystems have great potential for the treatment of sepsis-related liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SepsisBlood Coagulation DisordersHumansLiverDrug Delivery SystemsBlood Coagulation

Stichwörter der Autor:innen

bacterial translocationdrug delivery nanosystemsinflammatory responseliver-injuryoxidative stresssepsis

Autor:innen und Institutionen

  • ICU, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
  • Shulan International Medical College, Zhejiang Shuren University, Hangzhou, People's Republic of China.

Zitieren

APA

Lu, Y., Shi, Y., Wu, Q., Sun, X., Zhang, W. Z., Xu, X. L., & Chen, W. (2023). An Overview of Drug Delivery Nanosystems for Sepsis-Related Liver Injury Treatment. International Journal of Nanomedicine, Volume 18, 765-779. https://doi.org/10.2147/ijn.s394802

Vancouver

Lu Y, Shi Y, Wu Q, Sun X, Zhang WZ, Xu XL, et al. An Overview of Drug Delivery Nanosystems for Sepsis-Related Liver Injury Treatment. International Journal of Nanomedicine. 2023;Volume 18:765-779. doi:10.2147/ijn.s394802

BibTeX
@article{Lu2023,
  author = {Lu, Yi and Shi, Yi and Wu, Qian and Sun, Xin and Zhang, Wei-Zhen and Xu, Xiao-Ling and Chen, Wei},
  title = {An Overview of Drug Delivery Nanosystems for Sepsis-Related Liver Injury Treatment},
  journal = {International Journal of Nanomedicine},
  year = {2023},
  volume = {Volume 18},
  pages = {765--779},
  doi = {10.2147/ijn.s394802}
}
Kostenlos starten →